🇺🇸 Carboplatin Injection in United States

187 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 32 reports (17.11%)
  2. Dyspnoea — 30 reports (16.04%)
  3. Erythema — 21 reports (11.23%)
  4. Pruritus — 17 reports (9.09%)
  5. Vomiting — 17 reports (9.09%)
  6. Nausea — 16 reports (8.56%)
  7. Hypotension — 15 reports (8.02%)
  8. Diarrhoea — 14 reports (7.49%)
  9. Pyrexia — 13 reports (6.95%)
  10. Neutropenia — 12 reports (6.42%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Carboplatin Injection approved in United States?

Carboplatin Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Carboplatin Injection in United States?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.